(reported by the Company)
No items found
ENA Respiratory is developing a novel class of innate immunomodulators that have the capability to prevent respiratory viral infections, including COVID-19 and associated complications.
|Category:||Hardware & devices, Health & biotech|
|ASX Listing Code (if applicable):|
|Year of Commencement:||2020|
31 Queen Street, Melbourne, Victoria 3000, AU